Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-22-208827
Filing Date
2022-08-01
Accepted
2022-08-01 16:54:31
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 20-F/A d381344d20fa.htm   iXBRL 20-F/A 1303114
2 EX-12.1 d381344dex121.htm EX-12.1 10998
3 EX-12.2 d381344dex122.htm EX-12.2 10915
4 EX-13.1 d381344dex131.htm EX-13.1 4895
5 EX-15.1 d381344dex151.htm EX-15.1 1569
6 EX-15.2 d381344dex152.htm EX-15.2 1332
  Complete submission text file 0001193125-22-208827.txt   6973334

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rnlx-20210630.xsd EX-101.SCH 62739
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnlx-20210630_cal.xml EX-101.CAL 66400
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnlx-20210630_def.xml EX-101.DEF 277905
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnlx-20210630_lab.xml EX-101.LAB 526278
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnlx-20210630_pre.xml EX-101.PRE 411570
67 EXTRACTED XBRL INSTANCE DOCUMENT d381344d20fa_htm.xml XML 1077327
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 20-F/A | Act: 34 | File No.: 001-39387 | Film No.: 221125530
SIC: 8071 Services-Medical Laboratories